ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 133 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $32,000 | -58.4% | 16,500 | 0.0% | 0.00% | -57.1% |
| Q2 2015 | $77,000 | +6.9% | 16,500 | 0.0% | 0.01% | +40.0% |
| Q1 2015 | $72,000 | +26.3% | 16,500 | 0.0% | 0.01% | +150.0% |
| Q4 2014 | $57,000 | -17.4% | 16,500 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $69,000 | -28.9% | 16,500 | 0.0% | 0.00% | +100.0% |
| Q2 2014 | $97,000 | -6.7% | 16,500 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $104,000 | +7.2% | 16,500 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $97,000 | +11.5% | 16,500 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $87,000 | -31.5% | 16,500 | 0.0% | 0.00% | -33.3% |
| Q2 2013 | $127,000 | – | 16,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
| DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
| SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
| Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
| FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
| GAM Holding AG | 523,164 | $997,000 | 0.02% |
| STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |